Technology

AddToAny

Google+ Facebook Twitter Twitter

New monotest system launched

Launch Diagnostics is pleased to introduce the new VIrClia monotest system, an indirect chemiluminescent immunoassay for the detection of antibodies against infectious diseases in human serum or plasma samples.

Each monotest contains wells for automatic sample addition plus the reagents necessary to perform the assay.  

Assays are automatically processed on the VirClia instrument with VirClia processing and interpretation software. 

The easy-to-use system supports bar code identification, use of primary sample tubes within the instrument racks and is completely versatile, enabling the custom set up of different assays in a single run. The Vircell portfolio includes infectious disease ELISAs and IFAs.  
launchdiagnostics.com

Related Articles

soft tissue sarcoma CREDIT -shutterstock - 2302813459

Sarcoma relapse risk reduced by 43%

A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.

nephrotic syndrome you yes CREDIT - shutterstock -639997780

Under the microscope: nephrotic syndrome

This month: Nephrotic syndrome

eProtein Discovery side-CREDIT_Supplied

Tech round up: June 2024

Best new tech this month

Natural-killer cells attacking a cancer cel - CREDIT - Science-Photolibrary-f0339843

Predictive model for tumour-killing cells

Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.

Top